Henry Schein has elected Reed V. Tuckson, MD, to its Board of Directors.
Since 2014, Tuckson has served as managing director of Tuckson Health Connections, a health and medical care consulting business that promotes optimal health outcomes and value through innovation and integration, Henry Schein Said.
Tuckson also is the founder of the Black Coalition Against COVID-19, which seeks to provide trustworthy, science-based information curated for the Black community and other communities of color about COVID-19 vaccines and related topics to help save lives.
Previously, Tuckson served as executive vice president and chief of medical affairs for UnitedHealth Group, where he oversaw the company’s medical and clinical-related policies and activities. He also has held positions as:
- Senior vice president, professional standards, of the American Medical Association
- President of the Charles R. Drew University of Medicine and Science in Los Angeles
- Senior vice president for programs of the March of Dimes Birth Defects Foundation
- Commissioner of public health for the District of Columbia
“We are delighted to welcome Dr. Tuckson to the Henry Schein Board of Directors,” said Stanley M. Bergman, chair and chief executive officer for Henry Schein.
“Having worked for more than 35 years in nearly every sector of the health and medical care industries, Dr. Tuckson is a well-respected and innovative healthcare leader who is deeply skilled at bringing together a variety of stakeholder groups to catalyze change,” Bergman said.
“We look forward to the valuable perspective Dr. Tuckson will bring as we continue on our path to advance health equity, drive innovation, and serve our customers whose needs are rapidly evolving,” Begrman said.
Tuckson has been a member of numerous federal advisory committees and corporate, nonprofit, and academic boards. He currently serves on the boards of directors of CTI BioPharma and Adverum Biotechnologies.
Also, Tuckson is a member of the Howard University Board of Trustees, where he chairs the Health Sciences Committee. He is a member of the advisory board of the National Institutes of Health Clinical Center and serves on several committees of the National Academy of Medicine as well.
“I’m honored to join this distinguished board and have long admired the company’s commitment to a purpose-driven, values-based culture that balances the needs of all stakeholders,” said Tuckson.
“I look forward to joining my fellow board members to advance Henry Schein’s impressive commitment to a socially responsible future that includes addressing racial disparities in health access and outcomes while providing healthcare practitioners with the solutions needed to meet the global demand for quality patient care,” he said.
Tuckson received a BS from Howard University and an MD from Georgetown University School of Medicine. He completed the University of Pennsylvania Hospital’s General Internal Medicine Residency and Fellowship programs, where he was also a Robert Wood Johnson Foundation Clinical Scholar studying at the Wharton School of Business.